Interstitial fibrosis restricts osmotic water transport in encapsulating peritoneal sclerosis

Journal of the American Society of Nephrology

Volumn 26, Issue 10, 2015, Pages 2521-2533

  Morelle, Johann ^a   Sow, Amadou ^a   Hautem, Nicolas ^a   Bouzin, Caroline ^b   Crott, Ralph ^c   Devuyst, Olivier ^a,d   Goffin, Eric ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Institute of Experimental and Clinical Research   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 1; COLLAGEN; CREATININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; SODIUM; VASCULOTROPIN; WATER;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; COLLAGEN DENSITY; COLLAGEN METABOLISM; CONDUCTANCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; END STAGE RENAL DISEASE; FEMALE; HUMAN; HUMAN TISSUE; INDEPENDENT VARIABLE; KIDNEY FIBROSIS; KIDNEY FUNCTION TEST; LONG TERM CARE; MALE; MIDDLE AGED; OSMOLARITY AND OSMOLALITY; OSMOTIC CONDUCTANCE; PERITONEAL DIALYSIS; PERITONEAL EQUILIBRATION TEST; PERITONEAL FIBROSIS; PERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SODIUM URINE LEVEL; ULTRAFILTRATION; UPREGULATION; UREMIA; VASCULAR DISEASE; WATER TRANSPORT; ADVERSE EFFECTS; METABOLISM; OSMOSIS; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; BIOLOGICAL TRANSPORT; FEMALE; HUMANS; MALE; MIDDLE AGED; OSMOSIS; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; WATER;

EID: 84942623354     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014090939     Document Type: Article

References (55)

1. Jain AK, Blake P, Cordy P, Garg AX: Global trends in rates of peritoneal dialysis. J Am Soc Nephrol 23: 533-544, 2012.
2. Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E: Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 171: 110-118, 2011.
3. Davies SJ, Phillips L, Naish PF, Russell GI: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12: 1046-1051, 2001.
4. Devuyst O, Margetts PJ, Topley N: The pathophysiology of the peritoneal membrane. J Am Soc Nephrol 21: 1077-1085, 2010.
5. Devuyst O, van-Westrhenen R, Topley N: Longterm peritoneal dialysis patients. In: Nolph and Gokal's Textbook of Peritoneal Dialysis, editedby Khanna R, Krediet RT, 3rd Ed., New York, Springer, 2009, pp 757-780.
6. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI: What really happens to people on long-term peritoneal dialysis? Kidney Int 54: 2207-2217, 1998.
7. Williams JD, Craig KJ, Topley N, Von-Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT; Peritoneal Biopsy Study Group: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13: 470-479, 2002.
8. Williams JD, Craig KJ, von-Ruhland C, Topley N, Williams GT; Biopsy Registry Study Group: The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 88: S43-S49, 2003.
9. Honda K, Hamada C, Nakayama M, Miyazaki M, Sherif AM, Harada T, Hirano H; Peritoneal Biopsy Study Group of the Japanese Society for Peritoneal Dialysis: Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: A quantitative study of peritoneal membrane morphology. Clin J Am Soc Nephrol 3: 720- 728, 2008.
10. Korte MR, Sampimon DE, Betjes MG, Krediet RT: Encapsulating peritoneal sclerosis: the state of affairs. Nat Rev Nephrol 7: 528-538, 2011.
11. Brown MC, Simpson K, Kerssens JJ, Mactier RA; Scottish Renal Registry: Encapsulating peritoneal sclerosis in the new millennium: A national cohort study. Clin J Am Soc Nephrol 4: 1222-1229, 2009.
12. Johnson DW, Cho Y, Livingston BE, Hawley CM, McDonald SP, Brown FG, Rosman JB, Bannister KM, Wiggins KJ: Encapsulating peritoneal sclerosis: Incidence, predictors, and outcomes. Kidney Int 77: 904-912, 2010.
13. Korte MR, Sampimon DE, Lingsma HF, Fieren MW, Looman CW, Zietse R, Weimar W, Betjes MG; Dutch Multicenter EPS Study: Risk factors associated with encapsulating peritoneal sclerosis in Dutch EPS study. Perit Dial Int 31: 269-278, 2011.
14. Lambie ML, John B, Mushahar L, Huckvale C, Davies SJ: The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made. Kidney Int 78: 611-618, 2010.
15. Sampimon DE, Coester AM, Struijk DG, Krediet RT: The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis. Nephrol Dial Transplant 26: 291-298, 2011.
16. Ni J, Verbavatz JM, Rippe A, Boisdé I, Moulin P, Rippe B, Verkman AS, Devuyst O: Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis. Kidney Int 69: 1518-1525, 2006.
17. Papapetropoulos A, García-Cardeña G, Madri JA, Sessa WC: Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139, 1997.
18. Whittaker P, Boughner DR, Kloner RA: Analysis of healing after myocardial infarction using polarized light microscopy. Am J Pathol 134: 879-893, 1989.
19. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT: Targeted deletion of matrixmetalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106: 55-62, 2000.
20. Rippe B, Venturoli D: Simulations of osmotic ultrafiltration failure in CAPD using a serial three-pore membrane/fiber matrix model. Am J Physiol Renal Physiol 292: F1035-F1043, 2007.
21. Sampimon DE, Coester AM, Struijk DG, Krediet RT: Time course of peritoneal transport parameters in peritoneal dialysis patients who develop peritoneal sclerosis. Adv Perit Dial 23: 107-111, 2007.
22. La-Milia V, Pozzoni P, Virga G, Crepaldi M, Del-Vecchio L, Andrulli S, Locatelli F: Peritoneal transport assessment by peritoneal equilibration test with 3.86% glucose: A long-term prospective evaluation. Kidney Int 69: 927-933, 2006.
23. Mateijsen MA, van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, Krediet RT: Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 19: 517- 525, 1999.
24. Honda K, Nitta K, Horita S, Tsukada M, Itabashi M, Nihei H, Akiba T, Oda H: Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 19: 169-175, 2003.
25. Braun N, Fritz P, Ulmer C, Latus J, KimmelM, Biegger D, Ott G, Reimold F, Thon KP, Dippon J, Segerer S, Alscher MD: Histological criteria for encapsulating peritoneal sclerosis - A standardized approach. PLoS ONE 7: e48647, 2012.
26. Plum J, Hermann S, Fusshöller A, Schoenicke G, Donner A, Röhrborn A, Grabensee B: Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int Suppl 78: S42-S47, 2001.
27. Whittaker P, Kloner RA, Boughner DR, Pickering JG: Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic Res Cardiol 89: 397-410, 1994.
28. Davies SJ: Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 66: 2437- 2445, 2004.
29. Levick JR: Flow through interstitiumand other fibrousmatrices. Q J Exp Physiol 72: 409-437, 1987.
30. Ng CP, Hinz B, Swartz MA: Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro. J Cell Sci 118: 4731- 4739, 2005.
31. Flessner MF, Dedrick RL, Schultz JS: A distributed model of peritonealplasma transport: Theoretical considerations. Am J Physiol 246: R597- R607, 1984.
32. Flessner MF: Peritoneal transport physiology: Insights from basic research. J Am Soc Nephrol 2: 122-135, 1991.
33. Combet S, Miyata T, Moulin P, Pouthier D, Goffin E, Devuyst O: Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 11: 717-728, 2000.
34. Wynn TA, Ramalingam TR: Mechanisms of fibrosis: Therapeutic translation for fibrotic disease. Nat Med 18: 1028-1040, 2012.
35. Sekiguchi Y, Zhang J, Patterson S, Liu L, Hamada C, Tomino Y, Margetts PJ: Rapamycin inhibits transforming growth factor b-induced peritoneal angiogenesis by blocking the secondary hypoxic response. J Cell Mol Med 16: 1934-1945, 2012.
36. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, KearneyM, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM: Nitric oxide synthasemodulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578, 1998.
37. Ni J, Moulin P, Gianello P, Feron O, Balligand JL, Devuyst O:Mice that lack endothelial nitric oxide synthase are protected against functional and structural modifications induced by acute peritonitis. J Am Soc Nephrol 14: 3205-3216, 2003.
38. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439, 1996.
39. Carmeliet P, Jain RK: Molecularmechanisms and clinical applications of angiogenesis. Nature 473: 298-307, 2011.
40. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK: Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A 98: 2604-2609, 2001.
41. Lenting PJ, Casari C, Christophe OD, Denis CV: vonWillebrand factor: The old, the new and the unknown. J Thromb Haemost 10: 2428-2437, 2012.
42. Mojiri A, Nakhaii-Nejad M, Phan WL, Kulak S, Radziwon-Balicka A, Jurasz P, Michelakis E, Jahroudi N: Hypoxia results in upregulation and de novo activation of von Willebrand factor expression in lung endothelial cells. Arterioscler Thromb Vasc Biol 33: 1329-1338, 2013.
43. Vischer UM: von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost 4: 1186-1193, 2006.
44. Devuyst O, Rippe B: Water transport across the peritoneal membrane. Kidney Int 85: 750-758, 2014.
45. Rippe B, Stelin G, Haraldsson B: Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 40: 315-325, 1991.
46. Goffin E, Combet S, Jamar F, Cosyns JP, Devuyst O: Expression of aquaporin-1 in a long-term peritoneal dialysis patient with impaired transcellular water transport. Am J Kidney Dis 33: 383-388, 1999.
47. Smit W, Schouten N, van den Berg N, Langedijk MJ, Struijk DG, Krediet RT; Netherlands Ultrafiltration Failure Study Group: Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: A cross-sectional study. Perit Dial Int 24: 562-570, 2004.
48. Rippe B, de-Arteaga J, Venturoli D: Aquaporins are unlikely to be affected in marked ultrafiltration failure: Results from a computer simulation. Perit Dial Int 21[Suppl 3]: S30-S34, 2001.
49. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG; International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis: Encapsulating peritoneal sclerosis: Definition, etiology, diagnosis, and treatment. Perit Dial Int 20 [Suppl 4]: S43-S55, 2000.
50. Summers AM, Abrahams AC, Alscher MD, Betjes M, Boeschoten EW, Braun N, Brenchley PE, Davies S, Dunn L, Engelsman L, Fieren M, Garosi G, Goffin E, Heuveling L, Korte M, Lindholm B, Rutherford P, Struijk D, Verduijn M, Verger C, Westerhuis R: A collaborative approach to understanding EPS: The European perspective. Perit Dial Int 31: 245-248, 2011.
51. Clerbaux G, Francart J, Wallemacq P, Robert A, Goffin E: Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up. Nephrol Dial Transplant 21: 1032-1039, 2006.
52. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, Nielsen MP: Peritoneal equilibration test. Perit Dial Bull 7: 138-147, 1987.
53. Mujais S, Nolph K, Gokal R, Blake P, Burkart J, Coles G, Kawaguchi Y, Kawanishi H, Korbet S, Krediet R, Lindholm B, Oreopoulos D, Rippe B, Selgas R; International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis: Evaluation andmanagement of ultrafiltration problems in peritoneal dialysis. Perit Dial Int 20[Suppl 4]: S5-S21, 2000.
54. Devuyst O, Nielsen S, Cosyns JP, Smith BL, Agre P, Squifflet JP, Pouthier D, Goffin E: Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum. Am J Physiol 275: H234-H242, 1998.
55. De-Arteaga J, Ledesma F, Garay G, Chiurchiu C, de la Fuente J, Douthat W, Massari P, Terryn S, Devuyst O: High-dose steroid treatment increases freewater transport in peritoneal dialysis patients. Nephrol Dial Transplant 26: 4142-4145, 2011.